Conor Kilroy
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Conor Kilroy currently works at Aura Biosciences, Inc., as Secretary & Chief Legal Officer from 2025.
Mr. Kilroy also formerly worked at Boston Scientific Corp., as Counsel from 2012 to 2013, Goodwin Procter LLP, as Associate from 2007 to 2011, Ironwood Pharmaceuticals, Inc., as Secretary, Senior Vice President & General Counsel from 2020 to 2021, and Neurogastrx, Inc., as Secretary & General Counsel from 2021 to 2023.
Mr. Kilroy received his undergraduate degree from Brandeis University and graduate degree from Boston College Law School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,35% | 16-04-2026 | 217.835 ( 0,35% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AURA BIOSCIENCES, INC. | Algemeen Adviseur | 01-04-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Algemeen Adviseur | 01-05-2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-02-2021 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01-01-2013 |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01-01-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau